2-Bromo-5-iodoimidazo[2,1-b][1,3,4]thiadiazole, 95%, 1g

1-(2-Fluorophenyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 250mg

5-(5-methylfuran-2-yl)-1H-pyrazole, 95.0%, 5g

HBTU [Coupling Reagent for Peptide]>98.0%(HPLC)25g

3,5-Dimethyl-1H-pyrazole-4-carbaldehyde, 95.0%, 5g

5-Methyl-3-phenylisoxazole-4-carbaldehyde, 95.0%, 5g

tert-Butyl 3-(2-ethoxy-2-oxoethylidene)azetidine-1-carboxylate, 95.0%, 10g

N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide, 97%, 1g

(2-oxo-1,3-oxazolidin-3-yl)acetic acid, 95.0%, 5g

ETHYL 5-OXO-5,6,7,8-TETRAHYDROQUINOLINE-2-CARBOXYLATE, 95%, 1g

2-Bromo-5-methyl-4-nitropyridine 1-oxide, 95.0%, 100mg

(5-(4-Chlorophenyl)-3-isoxazolyl)methanol, 95.0%, 250mg

Ethyl 2-oxo-2-(1H-pyrazol-4-yl)acetate, 97%, 5g